Skip to main content

Pathology of Nonneoplastic Thymic Lesions

  • Chapter
  • First Online:
  • 900 Accesses

Abstract

The chapter on Nonneoplastic Thymic Lesions will cover the epidemiological, etiological and clinicopathological features of common thymic lesions (congenital and acquired cysts, including dysplasia); thymic follicular, rebound and “true” hyperplasia) as well as rare or recently described non-neoplastic thymic alterations that may form mass lesions and can mimic thymic neoplasms (“Lesa-like thymic hyperplasia”; “Cholesteroloma”; Fibrosing mediastinitis, including IgG4-related disease). Criteria concerning the broad spectrum of differential diagnoses will be highlighted.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   149.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   199.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   279.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Kozu Y, et al. Single institutional experience with primary mediastinal cysts: clinicopathological study of 108 resected cases. Ann Thorac Cardiovasc Surg. 2014;20(5):365–9.

    PubMed  Google Scholar 

  2. Esme H, et al. Primary mediastinal cysts: clinical evaluation and surgical results of 32 cases. Tex Heart Inst J. 2011;38(4):371–4.

    PubMed  PubMed Central  Google Scholar 

  3. Aydin Y, et al. Surgical treatment of mediastinal cysts: report on 29 cases. Acta Chir Belg. 2012;112(4):281–6.

    CAS  PubMed  Google Scholar 

  4. Kelleher CM, et al. Case records of the Massachusetts general hospital. Case 10-2012. A 16-year-old boy with epigastric pain and a mediastinal mass. N Engl J Med. 2012;366(13):1241–9.

    CAS  PubMed  Google Scholar 

  5. Takeda S, et al. Clinical spectrum of primary mediastinal tumors: a comparison of adult and pediatric populations at a single Japanese institution. J Surg Oncol. 2003;83(1):24–30.

    PubMed  Google Scholar 

  6. Nam JG, et al. Age- and gender-specific disease distribution and the diagnostic accuracy of CT for resected anterior mediastinal lesions. Thorac Cancer. 2019;10(6):1378–87.

    PubMed  PubMed Central  Google Scholar 

  7. Rosai J, Levine GD. Tumors of the thymus. In: Firminger HI, editor. Atlas of tumor pathology, vol. 13. 2nd ed. Washington, D.C.: Armed Forces Institute of Pathology; 1976. p. 228.

    Google Scholar 

  8. Haro Estarriol M, et al. Spontaneous resolution of a primary thymic cyst. An Med Interna. 2003;20(10):552–3.

    CAS  PubMed  Google Scholar 

  9. Schweigert M, et al. Thymoma within a giant congenital thymic cyst. Interact Cardiovasc Thorac Surg. 2011;13(4):442–3.

    PubMed  Google Scholar 

  10. Kitami A, et al. Thymoma with intracystic dissemination arising in a unilocular thymic cyst. Gen Thorac Cardiovasc Surg. 2007;55(7):281–3.

    PubMed  Google Scholar 

  11. Travis WD, et al. WHO classification of tumours of the lung, pleura, thymus and heart. In: Bosman FT, et al., editors. World health classification of tumours. 4th ed. Lyon: IARC; 2015.

    Google Scholar 

  12. Nakamura S, et al. Multilocular thymic cyst associated with thymoma: a clinicopathologic study of 20 cases with an emphasis on the pathogenesis of cyst formation. Am J Surg Pathol. 2012;36(12):1857–64.

    PubMed  Google Scholar 

  13. Asma B, et al. Acute respiratory failure revealing a multilocular thymic cyst in an infant: a case report. Cases J. 2009;2:9109.

    PubMed  PubMed Central  Google Scholar 

  14. Mishalani SH, Lones MA, Said JW. Multilocular thymic cyst. A novel thymic lesion associated with human immunodeficiency virus infection. Arch Pathol Lab Med. 1995;119(5):467–70.

    CAS  PubMed  Google Scholar 

  15. Nonaka D, Klimstra D, Rosai J. Thymic mucoepidermoid carcinomas: a clinicopathologic study of 10 cases and review of the literature. Am J Surg Pathol. 2004;28(11):1526–31.

    PubMed  Google Scholar 

  16. Matsumoto S, et al. Multilocular thymic cyst associated with rheumatoid arthritis. Kyobu Geka. 2012;65(3):205–8.

    PubMed  Google Scholar 

  17. Tamagno M, et al. Giant multilocular thymic cyst in an HIV-infected adolescent. J Pediatr Surg. 2011;46(9):1842–5.

    PubMed  Google Scholar 

  18. Suster S, Rosai J. Multilocular thymic cyst: an acquired reactive process. Study of 18 cases. Am J Surg Pathol. 1991;15(4):388–98.

    CAS  PubMed  Google Scholar 

  19. Izumi H, et al. Multilocular thymic cyst associated with follicular hyperplasia: clinicopathologic study of 4 resected cases. Hum Pathol. 2005;36(7):841–4.

    PubMed  Google Scholar 

  20. Suster S, et al. Multilocular thymic cysts with pseudoepitheliomatous hyperplasia. Hum Pathol. 1991;22(5):455–60.

    CAS  PubMed  Google Scholar 

  21. Osaki T, Nakagawa M. Multilocular mediastinal cyst with rim calcification: report of a case. Surg Today. 2008;38(1):52–5.

    PubMed  Google Scholar 

  22. Shen X, et al. Thymoma and thymic carcinoma associated with multilocular thymic cyst: a clinicopathologic analysis of 18 cases. Diagn Pathol. 2018;13(1):41.

    PubMed  PubMed Central  Google Scholar 

  23. Weissferdt A, Moran CA. Thymic carcinoma associated with multilocular thymic cyst: a clinicopathologic study of 7 cases. Am J Surg Pathol. 2011;35(7):1074–9.

    PubMed  Google Scholar 

  24. Moran CA, et al. Carcinomas arising in multilocular thymic cysts of the neck: a clinicopathological study of three cases. Histopathology. 2004;44(1):64–8.

    CAS  PubMed  Google Scholar 

  25. Huang WL, Tseng YL. Rare presentation of giant isolated enteric cyst in anterior mediastinum. Ann Thorac Surg. 2019;107(6):e417–9.

    PubMed  Google Scholar 

  26. Salyer DC, Salyer WR, Eggleston JC. Benign developmental cysts of the mediastinum. Arch Pathol Lab Med. 1977;101(3):136–9.

    CAS  PubMed  Google Scholar 

  27. Schweigert M, et al. The tale of spring water cysts: a historical outline of surgery for congenital pericardial diverticula and cysts. Tex Heart Inst J. 2012;39(3):330–4.

    PubMed  PubMed Central  Google Scholar 

  28. Park JG, et al. Mediastinal lymphangioma: Mayo clinic experience of 25 cases. Mayo Clin Proc. 2006;81(9):1197–203.

    PubMed  Google Scholar 

  29. Kadota Y, et al. Lymphatic and venous malformation or “lymphangiohemangioma” of the anterior mediastinum: case report and literature review. Gen Thorac Cardiovasc Surg. 2011;59(8):575–8.

    PubMed  Google Scholar 

  30. Moran CA, Suster S. Thymoma with prominent cystic and hemorrhagic changes and areas of necrosis and infarction: a clinicopathologic study of 25 cases. Am J Surg Pathol. 2001;25(8):1086–90.

    CAS  PubMed  Google Scholar 

  31. Suster S, Rosai J. Thymic carcinoma. A clinicopathologic study of 60 cases. Cancer. 1991;67(4):1025–32.

    CAS  PubMed  Google Scholar 

  32. Suster S, Rosai J. Cystic thymomas. A clinicopathologic study of ten cases. Cancer. 1992;69(1):92–7.

    CAS  PubMed  Google Scholar 

  33. Rieker RJ, et al. Cystic thymoma. Pathol Oncol Res. 2005;11(1):57–60.

    PubMed  Google Scholar 

  34. Brown JG, et al. Thymic basaloid carcinoma: a clinicopathologic study of 12 cases, with a general discussion of basaloid carcinoma and its relationship with adenoid cystic carcinoma. Am J Surg Pathol. 2009;33(8):1113–24.

    PubMed  Google Scholar 

  35. Moser B, et al. Adenocarcinoma of the thymus, enteric type: report of 2 cases, and proposal for a novel subtype of thymic carcinoma. Am J Surg Pathol. 2015;39(4):541–8.

    PubMed  Google Scholar 

  36. Weissferdt A, Kalhor N, Moran CA. Cystic well-differentiated squamous cell carcinoma of the thymus: a clinicopathological and immunohistochemical study of six cases. Histopathology. 2016;68(3):333–8.

    PubMed  Google Scholar 

  37. Lindholm KE, Moran CA. Cystic and encapsulated atypical thymoma (World Health Organization Type B3). Am J Clin Pathol. 2019;152(4):512–6.

    PubMed  Google Scholar 

  38. Betts G, Beckett E, Nonaka D. GATA3 shows differential immunohistochemical expression across thyroid and parathyroid lesions. Histopathology. 2014;65(2):288–90.

    PubMed  Google Scholar 

  39. Tulay CM. Primary mediastinal hydatid cysts. Ann Thorac Cardiovasc Surg. 2014;20(4):316–9.

    PubMed  Google Scholar 

  40. Sabzi F, Faraji R. A rare case of anterior mediastinal mass caused by Brucella infection. Asian Cardiovasc Thorac Ann. 2017;25(3):222–5.

    PubMed  Google Scholar 

  41. Mao JC, et al. Craniocervical necrotizing fasciitis with and without thoracic extension: management strategies and outcome. Am J Otolaryngol. 2009;30(1):17–23.

    PubMed  Google Scholar 

  42. Strobel P, et al. The ageing and myasthenic thymus: a morphometric study validating a standard procedure in the histological workup of thymic specimens. J Neuroimmunol. 2008;201–202:64–73.

    PubMed  Google Scholar 

  43. Middleton G, Schoch EM. The prevalence of human thymic lymphoid follicles is lower in suicides. Virchows Arch. 2000;436(2):127–30.

    CAS  PubMed  Google Scholar 

  44. Marx A, et al. Thymus pathology observed in the MGTX trial. Ann N Y Acad Sci. 2012;1275:92–100.

    CAS  PubMed  Google Scholar 

  45. Alpert LI, et al. A histologic reappraisal of the thymus in myasthenia gravis. A correlative study of thymic pathology and response to thymectomy. Arch Pathol. 1971;91(1):55–61.

    CAS  PubMed  Google Scholar 

  46. Koneczny I, et al. Characterization of the thymus in Lrp4 myasthenia gravis: four cases. Autoimmun Rev. 2019;18(1):50–5.

    CAS  PubMed  Google Scholar 

  47. Zisimopoulou P, et al. A comprehensive analysis of the epidemiology and clinical characteristics of anti-LRP4 in myasthenia gravis. J Autoimmun. 2014;52:139–45.

    CAS  PubMed  Google Scholar 

  48. Leite MI, et al. Fewer thymic changes in MuSK antibody-positive than in MuSK antibody-negative MG. Ann Neurol. 2005;57(3):444–8.

    PubMed  Google Scholar 

  49. Dalla Costa M, Mangano FA, Betterle C. Thymic hyperplasia in patients with Graves’ disease. J Endocrinol Investig. 2014;37(12):1175–9.

    CAS  Google Scholar 

  50. Hofmann WJ, Moller P, Otto HF. Thymic hyperplasia. II. Lymphofollicular hyperplasia of the thymus. An immunohistologic study. Klin Wochenschr. 1987;65(2):53–60.

    CAS  PubMed  Google Scholar 

  51. Meyer A, Levy Y. Geoepidemiology of myasthenia gravis [corrected]. Autoimmun Rev. 2010;9(5):A383–6.

    PubMed  Google Scholar 

  52. Maniaol AH, et al. Late onset myasthenia gravis is associated with HLA DRB1∗15:01 in the Norwegian population. PLoS One. 2012;7(5):e36603.

    CAS  PubMed  PubMed Central  Google Scholar 

  53. Seldin MF, et al. Genome-wide association study of late-onset myasthenia gravis: confirmation of TNFRSF11A and identification of ZBTB10 and three distinct HLA associations. Mol Med. 2016;21(1):769–81.

    PubMed  Google Scholar 

  54. Chuang WY, et al. Late-onset myasthenia gravis - CTLA4(low) genotype association and low-for-age thymic output of naive T cells. J Autoimmun. 2014;52:122–9.

    CAS  PubMed  Google Scholar 

  55. Giraud M, et al. An IRF8-binding promoter variant and AIRE control CHRNA1 promiscuous expression in thymus. Nature. 2007;448(7156):934–7.

    CAS  PubMed  Google Scholar 

  56. Gregersen PK, et al. Risk for myasthenia gravis maps to a (151) Pro-->Ala change in TNIP1 and to human leukocyte antigen-B∗08. Ann Neurol. 2012;72(6):927–35.

    CAS  PubMed  PubMed Central  Google Scholar 

  57. Renton AE, et al. A genome-wide association study of myasthenia gravis. JAMA Neurol. 2015;72(4):396–404.

    PubMed  PubMed Central  Google Scholar 

  58. Gradolatto A, et al. Both Treg cells and Tconv cells are defective in the Myasthenia gravis thymus: roles of IL-17 and TNF-alpha. J Autoimmun. 2014;52:53–63.

    CAS  PubMed  Google Scholar 

  59. Vincent A, et al. In-vitro synthesis of anti-acetylcholine-receptor antibody by thymic lymphocytes in myasthenia gravis. Lancet. 1978;1(8059):305–7.

    CAS  PubMed  Google Scholar 

  60. Wakkach A, et al. Expression of acetylcholine receptor genes in human thymic epithelial cells: implications for myasthenia gravis. J Immunol. 1996;157(8):3752–60.

    CAS  PubMed  Google Scholar 

  61. Kao I, Drachman DB. Thymic muscle cells bear acetylcholine receptors: possible relation to myasthenia gravis. Science. 1977;195(4273):74–5.

    CAS  PubMed  Google Scholar 

  62. Leite MI, et al. Myasthenia gravis thymus: complement vulnerability of epithelial and myoid cells, complement attack on them, and correlations with autoantibody status. Am J Pathol. 2007;171(3):893–905.

    PubMed  PubMed Central  Google Scholar 

  63. Hohlfeld R, Wekerle H. Reflections on the “intrathymic pathogenesis” of myasthenia gravis. J Neuroimmunol. 2008;201–202:21–7.

    PubMed  Google Scholar 

  64. Wolfe GI, et al. Long-term effect of thymectomy plus prednisone versus prednisone alone in patients with non-thymomatous myasthenia gravis: 2-year extension of the MGTX randomised trial. Lancet Neurol. 2019;18(3):259–68.

    CAS  PubMed  PubMed Central  Google Scholar 

  65. Suster S, Moran CA. Micronodular thymoma with lymphoid B-cell hyperplasia: clinicopathologic and immunohistochemical study of eighteen cases of a distinctive morphologic variant of thymic epithelial neoplasm. Am J Surg Pathol. 1999;23(8):955–62.

    CAS  PubMed  Google Scholar 

  66. Weissferdt A, Moran CA. Micronodular thymic carcinoma with lymphoid hyperplasia: a clinicopathological and immunohistochemical study of five cases. Mod Pathol. 2012;25(7):993–9.

    PubMed  Google Scholar 

  67. Weissferdt A, Moran CA. Thymic hyperplasia with lymphoepithelial sialadenitis (LESA)-like features: a clinicopathologic and immunohistochemical study of 4 cases. Am J Clin Pathol. 2012;138(6):816–22.

    PubMed  Google Scholar 

  68. Marchevsky A, et al. Policies and reporting guidelines for small biopsy specimens of mediastinal masses. J Thorac Oncol. 2011;6(Suppl 3):S1724–9.

    PubMed  Google Scholar 

  69. Inagaki H, et al. Primary thymic extranodal marginal-zone B-cell lymphoma of mucosa-associated lymphoid tissue type exhibits distinctive clinicopathological and molecular features. Am J Pathol. 2002;160(4):1435–43.

    PubMed  PubMed Central  Google Scholar 

  70. Aoki M, et al. A case of resected plasma cell type castleman’s disease with intramediastinal lymph nodes spread. Ann Thorac Cardiovasc Surg. 2014;20:682–5.

    PubMed  Google Scholar 

  71. Tani T, et al. A case of true thymic hyperplasia showing slow growth as revealed by chest X-ray. Nihon Kyobu Shikkan Gakkai Zasshi. 1994;32(2):194–8.

    CAS  PubMed  Google Scholar 

  72. Judd RL. Massive thymic hyperplasia with myoid cell differentiation. Hum Pathol. 1987;18(11):1180–3.

    CAS  PubMed  Google Scholar 

  73. Eifinger F, et al. True thymic hyperplasia associated with severe thymic cyst bleeding in a newborn: case report and review of the literature. Ann Diagn Pathol. 2007;11(5):358–62.

    PubMed  Google Scholar 

  74. Strobel P, et al. Deficiency of the autoimmune regulator AIRE in thymomas is insufficient to elicit autoimmune polyendocrinopathy syndrome type 1 (APS-1). J Pathol. 2007;211(5):563–71.

    CAS  PubMed  Google Scholar 

  75. Marx A, et al. The 2015 World Health Organization classification of tumors of the thymus: continuity and changes. J Thorac Oncol. 2015;10(10):1383–95.

    CAS  PubMed  PubMed Central  Google Scholar 

  76. Adam P, et al. Thymoma with loss of keratin expression (and giant cells): a potential diagnostic pitfall. Virchows Arch. 2014;465(3):313–20.

    CAS  PubMed  Google Scholar 

  77. Balbach ST, et al. Proposal of a genetic classifier for risk group stratification in pediatric T-cell lymphoblastic lymphoma reveals differences from adult T-cell lymphoblastic leukemia. Leukemia. 2016;30(4):970–3.

    CAS  PubMed  Google Scholar 

  78. Burkhardt B, Hermiston ML. Lymphoblastic lymphoma in children and adolescents: review of current challenges and future opportunities. Br J Haematol. 2019;185(6):1158–70.

    PubMed  Google Scholar 

  79. Oschlies I, et al. Diagnosis and immunophenotype of 188 pediatric lymphoblastic lymphomas treated within a randomized prospective trial: experiences and preliminary recommendations from the European childhood lymphoma pathology panel. Am J Surg Pathol. 2011;35(6):836–44.

    PubMed  Google Scholar 

  80. Pilozzi E, et al. Gene rearrangements in T-cell lymphoblastic lymphoma. J Pathol. 1999;188(3):267–70.

    CAS  PubMed  Google Scholar 

  81. den Bakker MA, Oosterhuis JW. Tumours and tumour-like conditions of the thymus other than thymoma; a practical approach. Histopathology. 2009;54(1):69–89.

    Google Scholar 

  82. Shimosato Y, Mukai K, Matsuno Y. Tumors of the mediastinum. Washington, DC: American Registry of Pathology; 2010.

    Google Scholar 

  83. Tabarin A, et al. Paraneoplastic Cushing’s syndrome. Pseudotumors of the thymus occurring after correction of hypercorticism. 3 cases. Presse Med. 1993;22(38):1908–10, 1915.

    CAS  PubMed  Google Scholar 

  84. Chertoff J, Barth RA, Dickerman JD. Rebound thymic hyperplasia five years after chemotherapy for Wilms’ tumor. Pediatr Radiol. 1991;21(8):596–7.

    CAS  PubMed  Google Scholar 

  85. Kissin CM, et al. Benign thymic enlargement in adults after chemotherapy: CT demonstration. Radiology. 1987;163(1):67–70.

    CAS  PubMed  Google Scholar 

  86. Jeon TJ, et al. Rebound thymic hyperplasia detected by 18F-FDG PET/CT after radioactive iodine ablation therapy for thyroid cancer. Thyroid. 2014;24(11):1636–41.

    CAS  PubMed  PubMed Central  Google Scholar 

  87. Priola AM, et al. Nonsuppressing normal thymus on chemical-shift MR imaging and anterior mediastinal lymphoma: differentiation with diffusion-weighted MR imaging by using the apparent diffusion coefficient. Eur Radiol. 2018;28(4):1427–37.

    PubMed  Google Scholar 

  88. Richmond BW, et al. Genome-wide association study of 58 individuals with Fibrosing Mediastinitis reveals possible underlying genetic susceptibility. Am J Respir Crit Care Med. 2018;197(9):1219–20.

    CAS  PubMed  PubMed Central  Google Scholar 

  89. Flieder DB, Suster S, Moran CA. Idiopathic fibroinflammatory (fibrosing/sclerosing) lesions of the mediastinum: a study of 30 cases with emphasis on morphologic heterogeneity. Mod Pathol. 1999;12(3):257–64.

    CAS  PubMed  Google Scholar 

  90. Takanashi S, et al. IgG4-related fibrosing mediastinitis diagnosed with computed tomography-guided percutaneous needle biopsy: two case reports and a review of the literature. Medicine (Baltimore). 2018;97(22):e10935.

    Google Scholar 

  91. Giorgadze T, et al. Postradiation-associated sclerosing mediastinitis diagnosed in fine needle aspiration specimen: a cytological-pathological correlation. Ann Diagn Pathol. 2017;27:43–7.

    PubMed  Google Scholar 

  92. Peikert T, et al. Fibrosing mediastinitis: clinical presentation, therapeutic outcomes, and adaptive immune response. Medicine (Baltimore). 2011;90(6):412–23.

    Google Scholar 

  93. Zhou Y, et al. Pulmonary vascular involvement of IgG4-related disease: case series with a PRISMA-compliant systemic review. Medicine (Baltimore). 2019;98(6):e14437.

    Google Scholar 

  94. Peikert T, et al. Histopathologic overlap between Fibrosing Mediastinitis and IgG4-related disease. Int J Rheumatol. 2012;2012:207056.

    PubMed  PubMed Central  Google Scholar 

  95. Sfyroeras GS, et al. A review of open and endovascular treatment of superior vena cava syndrome of benign aetiology. Eur J Vasc Endovasc Surg. 2017;53(2):238–54.

    CAS  PubMed  Google Scholar 

  96. Weissferdt A, Moran CA. The impact of neoadjuvant chemotherapy on the histopathological assessment of thymomas: a clinicopathological correlation of 28 cases treated with a similar regimen. Lung. 2013;191(4):379–83.

    CAS  PubMed  Google Scholar 

  97. Weissferdt A, Kalhor N, Moran C. Primary thymic cholesteroloma: a clinicopathological correlation of four cases of an unusual benign lesion. Virchows Arch. 2015;467(5):609–11.

    PubMed  Google Scholar 

  98. Ezzat TF, Alowami S. Cholesterol granuloma of the anterior mediastinum with osseous metaplasia. Rare Tumors. 2012;4(4):e47.

    PubMed  PubMed Central  Google Scholar 

  99. Krishnan TR, Sinha SK, Kejriwal NK. A rare case of cholesterol granuloma in the anterior mediastinum. Heart Lung Circ. 2013;22(4):303–4.

    PubMed  Google Scholar 

  100. Fujimoto K, et al. Focal cholesterol granuloma in the anterior mediastinum: [18F]-fluoro-2-deoxy-D-glucose-positron emission tomography and magnetic resonance imaging findings. J Thorac Oncol. 2007;2(11):1054–6.

    PubMed  Google Scholar 

  101. Luckraz H, Coulston J, Azzu A. Cholesterol granuloma of the superior mediastinum. Ann Thorac Surg. 2006;81(4):1509–10.

    PubMed  Google Scholar 

  102. Hamza A, Weissferdt A. Non-neoplastic and benign tumoral lesions of the thymic gland: a review and update. Adv Anat Pathol. 2019;26(4):257–69.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Alexander Marx .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Marx, A. (2020). Pathology of Nonneoplastic Thymic Lesions. In: Jain, D., Bishop, J.A., Wick, M.R. (eds) Atlas of Thymic Pathology. Springer, Singapore. https://doi.org/10.1007/978-981-15-3164-4_5

Download citation

  • DOI: https://doi.org/10.1007/978-981-15-3164-4_5

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-15-3163-7

  • Online ISBN: 978-981-15-3164-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics